Pharmacy Disclosure Log 2022

  1. Biologic and Biosimilar Products within Rheumatology Response 7421
  2. Biologic Medications within Dermatology Response 7390
  3. Breast Cancer Response 7291
  4. Breast Cancer Patients Response 7534
  5. Colorectal Cancer Response 7565
  6. CQUIN Response 7375
  7. CQUIN Data Response 7511
  8. Dermatology Drugs Response 7432
  9. Dermatology Patients Response 7388
  10. Diffuse Large B Cell Lymphoma Response 7544
  11. Gastric and Gastro-Oesophageal Junction Cancer Response 7335
  12. Gastric and Gastro-Oesophageal Response 7554
  13. Hartmann IV solution Response 7405
  14. Hepatocellular Carcinoma Response 7325
  15. Hidradenitis Suppurativa Response 7666
  16. Immunoglobulin Treatments Response 7326
  17. Immune Thrombocytopenia Response 7368
  18. Immune Thrombocytopenia Response 7368 - Attachment
  19. Jakavi Response 7370
  20. Lung Cancer Treatment Response 7373
  21. Melanoma Response 7371
  22. Multiple Myeloma Response 7318
  23. New Biologic Medications within Dermatology Response 7600
  24. Non-Small Cell Lung Cancer (NSCLC) Response 7479
  25. Non-Small Cell lung Cancer (NSCLC) Response 7286
  26. Patients Receiving Treatment Response 7536
  27. Patients Treated for Renal Cell Carcinoma Response 7491
  28. Patients Treated for Cervical Cancer Response 7648
  29. Patients treated with a combination of Dabrafenib and Trametinib Response 7512
  30. Patients treated with Anidulafungin Response 7505
  31. Patients Treated with Revolade, Nplate, Doptelet, Tavlesse Response 7616
  32. Patients Treated with Revolade, Nplate, Doptelet, Tavlesse Response 7616 - Attachment
  33. Prostate Cancer Response 7331
  34. Rheumatoid Arthritis Response 7523
  35. Rheumatoid Arthritis Response 7523 - Attachment
  36. Rheumatology Treatment Response 7269
  37. Rheumatology Response 7647
  38. Treatment for Lung Cancer Response 7623
  39. Systemic Anti-Cancer Therapies Response 7499
  40. The Treatment of Melanoma Response 7577
  41. Triple Negative Breast Response 7315
  42. Urothelial Cancer Patients Response 7324
  43. Urothelial Cancer Patients Response 7538
  44. Usage of Somatropins Response 7458

Last Modified: 1:21pm 04/10/2022

Pharmacy Disclosure Log 2022In this section